Litcius/Paper detail

Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer

Xinyi Guo, Hu Nie, Wenwen Zhang, Jiesheng Li, Jing Ge, Bowen Xie, Wenbo Hu, Yicheng Zhu, Na Zhong, Xinmei Zhang, Xiaohong Zhao, Xiaoshuang Wang, Qinli Sun, Kun Wei, Xiaoyuan Chen, Ling Ni, Ting Zhang, Shichun Lu, Lei Zhang, Chen Dong

2025Cancer Cell67 citationsDOI

Topics & Concepts

LenvatinibCytotoxic T cellCancerCancer researchMedicineOncologyImmunologyBiologyInternal medicineGeneticsIn vitroThyroid cancerCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmune Cell Function and Interaction
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer | Litcius